Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

AIDS

Volumn 20, Issue 12, 2006, Pages 1613-1619

  Bisson, Gregory P ^a   Gross, Robert ^a   Strom, Jordan B ^b   Rollins, Caitlin ^a   Bellamy, Scarlett ^a   Weinstein, Rachel ^a   Friedman, Harvey ^a   Dickinson, Diana ^c   Frank, Ian ^a   Strom, Brian L ^a   Gaolathe, Tendani ^d   Ndwapi, Ndwapi ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY   (United States)

^c Independence Surgery   (Botswana)

^d PRINCESS MARINA HOSPITAL   (Botswana)

Author keywords

Africa; Cohort study; HAART; HIV 1; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RNA, VIRAL; ROC CURVE; TIME FACTORS; VIRAL LOAD;

EID: 33746780699     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000238407.00874.dc     Document Type: Article

References (33)

1. Hammer SM. Advances in antiretroviral therapy and viral load monitoring. AIDS 1996; 10 (suppl 3):S1-S11.
2. Holodniy M. Viral load monitoring in HIV infection. Curr Infect Dis Rep 1999; 1:497-503.
3. Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med 1997; 126:929-938.
4. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005; 353:2325-2334.
5. WHO. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. 2003 Revision. Geneva, Switzerland: World Health Organization; 2004.
6. Wools-Kaloustian K, Kimaiyo S, Diero L, Siika A, Sidle J, Yiannoutsos CT, et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 2006; 20:41-48.
7. Wood E, Yip B, Hogg RS, Sherlock CH, Jahnke N, Harrigan RP, et al. Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy. AIDS 2000; 14:1955-1960.
8. Gange SJ, Schneider MF, Grant RM, Liegler T, French A, Young M, et al. Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure. J Acquir Immune Defic Syndr 2006; 41:68-74.
9. Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD. Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:20-26.
10. Lawn SD, Myer L, Bekker LG, Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 2006; 6:59.
11. Grabar S, Moing VL, Goujard C, Egger M, Leport C, Kazatchkine MD, et al. Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection. J Acquir Immune Defic Syndr 2005; 39:284-292.
12. Redelmeier DA, Lustig AJ. Prognostic indices in clinical practice. JAMA 2001; 285:3024-3025.
13. Stiell IG, Wells GA, Hoag RH, Sivilotti ML, Cacciotti TF, Verbeek PR, et al. Implementation of the Ottawa Knee Rule for the use of radiography in acute knee injuries. JAMA 1997;278:2075-2079.
14. Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter T, et al. Initial response to highly active antiretroviral therapy in HIV-1C infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr 2005;40:336-340.
15. Jagodzinski LL, Wiggins DL, McManis JL, Emery S, Overbaugh J, Robb M, et al. Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol 2000; 38:1247-1249.
16. Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004; 39:609-629.
17. Rosner B. Fundamentals of biostatistics. 5th ed.. Pacific Grove: Brooks/Cole; 2000.
18. Efron B. Estimating the error rate of a prediction rule: Improvement on cross-validation. J Am Stat Assoc 1983; 78:316-331.
19. Piketty C, Castiel P, Belec L, Batisse D, Si Mohamed A, Gilquin J, et al. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 1998; 12:745-750.
20. Kaufmann D, Pantaleo G, Sudre P, Telenti A. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet 1998; 351:723-724.
21. Ripamonti D, Arici C, Maggiolo F, Finazzi MG, Suter F. Discordant immunological response in HIV-positive patients on non-nucleoside reverse transcriptase inhibitor-based regimens. AIDS 2002; 16:130-131.
22. UNAIDS WHO. Progress of global access to HIV antiretroviral therapy. An update on '3 by 5'. Geneva, Switzerland: UNAIDS WHO; June 2005.
23. DeHovitz JA, Kovacs A, Feldman JG, Anastos K, Young M, Cohen M, et al. The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's interagency HIV study. J Infect Dis 2000; 182:1527-1530.
24. Yamashita TE, Phair JP, Munoz A, Margolick JB, Detels R, O'Brien SJ, et al. Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. AIDS 2001; 15:735-746.
25. Kaufmann GR, Bloch M, Finlayson R, Zaunders J, Smith D, Cooper DA. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS 2002; 16:359-367.
26. Le Moing V, Thiebaut R, Chene G, Leport C, Cailleton V, Michelet C, et al. Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen. J Infect Dis 2002; 185:471-480.
27. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18:887-895.
28. Laurent C, Kouanfack C, Koulla-Shiro S, Nkoue N, Bourgeois A, Calmy A, et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet 2004; 364:29-34.
29. Lawn SD, Myer L, Orrell C, Bekker L-G, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005; 19:2141-2148.
30. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006; 367:1335-1342.
31. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA 2000;284:79-84.
32. Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006; 144:201-209.
33. Rosen S, Sanne I, Collier A, Simon JL. Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa. Lancet 2005;365:354-356.